Pub. Date : 2019 Apr
PMID : 30320903
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Cotreatment of either purvalanol or roscovitine with ERK1/2 inhibitor, U0126, synergistically suppressed cell proliferation, and induced apoptotic action. | purvalanol B | mitogen-activated protein kinase 3 | Homo sapiens |
2 | This study provides biological evidence about purvalanol and roscovitine have apoptotic and antimetastatic effects via MAPK signaling on prostate cancer cell by activation of GSK3beta signaling and inhibition of phosphoinositide-3-kinase/AKT (PI3K/AKT) pathways involved in the EMT process. | purvalanol B | mitogen-activated protein kinase 3 | Homo sapiens |